CIA
EMN icon

Cladis Investment Advisory’s Eastman Chemical EMN Stock Holding History

Cladis Investment Advisory’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$224K – 135
2024
Q3 		$224K Buy
+2,000
New +$200K 0.16% 121
2024
Q2 		– Sell
-2,000
Closed -$200K – 140
2024
Q1 		$200K Buy
+2,000
New +$176K 0.15% 138
2022
Q2 		– Sell
-2,000
Closed -$224K – 136
2022
Q1 		$224K Hold
2,000
– – 0.18% 132
2021
Q4 		$242K Buy
+2,000
New +$222K 0.19% 129

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cladis Investment Advisory's EMN Position: Q4 2024 in Review

Cladis Investment Advisory sold out of Eastman Chemical (EMN) in Q4 2024, closing a stake of 2,000 shares — an estimated $224K sold.

Cladis Investment Advisory first reported a position in EMN in Q4 2021 and held it in 4 quarters. The position peaked at $242K in Q4 2021. 785 funds tracked by Wall St. Rank hold EMN as of Q4 2024.

  • Cladis Investment Advisory reported no remaining Eastman Chemical position as of Q4 2024 after selling out during the quarter.
  • Cladis Investment Advisory sold 2,000 Eastman Chemical shares in Q4 2024, an estimated $224K.
  • Cladis Investment Advisory first reported a position in Eastman Chemical in Q4 2021 and held it in 4 quarters.
  • Cladis Investment Advisory's Eastman Chemical position peaked at $242K in Q4 2021.
  • 785 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2024.

Based on Cladis Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.